SCHEMBL1777397

SCHEMBL1777397

COCCNC(=O)c1ccnc2[nH]c(-c3c[nH]c4ccc(OC)cc34)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.60
HSD17B10 Q99714 3/20 0.60
LMNA P02545 2/20 0.60
PYGL P06737 1/20 0.48
HTR4 Q13639 2/20 0.46
KMT2A Q03164 3/20 0.46
CPT1A P50416 1/20 0.46
POLB P06746 1/20 0.46
AURKA O14965 1/20 0.45
MET P08581 1/20 0.45
KDR P35968 1/20 0.45
TEK Q02763 1/20 0.45
RAB9A P51151 3/20 0.44
MEN1 O00255 2/20 0.44
MITF O75030 1/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MTNR1A P48039 4/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777605 0.88 NR4A2 (0.47) KDM4EHSD17B10LMNAHTR4KMT2A
SCHEMBL1777482 0.85 LMNA (0.52) KDM4EHSD17B10LMNAKMT2ACPT1A
SCHEMBL1777004 0.84 KDM4E (0.53) KDM4EHSD17B10LMNAKMT2ACPT1A
Potassium Ion SCHEMBL1779429 0.84 NR4A2 (0.47) KDM4EHSD17B10LMNAKMT2ACPT1A
SCHEMBL13157658 0.83 NR4A2 (0.46) KDM4EHSD17B10LMNAKMT2ACPT1A
SCHEMBL1777620 0.82 IGF1R (0.58) KDM4EHSD17B10LMNAAURKAMET
SCHEMBL1778147 0.81 NR4A2 (0.47) KDM4EHSD17B10LMNAKMT2ACPT1A
SCHEMBL1779530 0.78 MAP3K14 (0.53) KDM4EHSD17B10KMT2AKDRMEN1
SCHEMBL1779702 0.77 MAP3K14 (0.52) KDM4EHSD17B10LMNAKMT2AMEN1
SCHEMBL1778255 0.76 KDR (0.47) KDM4EHSD17B10LMNAKMT2AAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 US disclosed
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 US disclosed
EP-2233486-A1 Azaindoles Aventis Pharma Limited (GB) 2010-09-29 EP disclosed